Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Randall

Showing results (431-440 of 456) with videos related to

Pageof 46
Sort By:
European Journal of Immunology|February 11, 2025
ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in HumansAndri Vasou, Katie Nightingale, Vladimíra Cetkovská, et al.
The Pediatric Infectious Disease Journal|November 30, 2006
Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathyJesús Saavedra-Lozano, José T Ramos, Francisco Sanz, et al.
Plos Genetics|June 13, 2020
Elevated exopolysaccharide levels in Pseudomonas aeruginosa flagellar mutants have implications for biofilm growth and chronic infectionsJoe J Harrison, Henrik Almblad, Yasuhiko Irie, et al.
The Journal of Biological Chemistry|July 1, 2020
PelX is a UDP-<i>N</i>-acetylglucosamine C4-epimerase involved in Pel polysaccharide-dependent biofilm formationLindsey S Marmont, Gregory B Whitfield, Roland Pfoh, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Future Oncology (London, England)|January 8, 2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancerGary D Steinberg, Neal D Shore, Joan Palou Redorta, et al.
Frontiers in Immunology|September 26, 2022
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteriaVanessa Daza-Cajigal, Adriana S Albuquerque, Dan F Young, et al.
The Lancet. Infectious Diseases|May 3, 2026
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort studyAmanda C Miles, Jelena Vojicic, Paula Peyrani, et al.
Mbio|April 25, 2023
The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus InfectionAlexandra Hardy, Siddharth Bakshi, Wilhelm Furnon, et al.
Nature Protocols|October 23, 2015
Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchangeLaura R Hmelo, Bradley R Borlee, Henrik Almblad, et al.
Pageof 46

Showing results (431-440 of 456) with videos related to

Sort By:
Pageof 46
European Journal of Immunology|February 11, 2025
ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in HumansAndri Vasou, Katie Nightingale, Vladimíra Cetkovská, et al.
The Pediatric Infectious Disease Journal|November 30, 2006
Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathyJesús Saavedra-Lozano, José T Ramos, Francisco Sanz, et al.
Plos Genetics|June 13, 2020
Elevated exopolysaccharide levels in Pseudomonas aeruginosa flagellar mutants have implications for biofilm growth and chronic infectionsJoe J Harrison, Henrik Almblad, Yasuhiko Irie, et al.
The Journal of Biological Chemistry|July 1, 2020
PelX is a UDP-<i>N</i>-acetylglucosamine C4-epimerase involved in Pel polysaccharide-dependent biofilm formationLindsey S Marmont, Gregory B Whitfield, Roland Pfoh, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Future Oncology (London, England)|January 8, 2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancerGary D Steinberg, Neal D Shore, Joan Palou Redorta, et al.
Frontiers in Immunology|September 26, 2022
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteriaVanessa Daza-Cajigal, Adriana S Albuquerque, Dan F Young, et al.
The Lancet. Infectious Diseases|May 3, 2026
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort studyAmanda C Miles, Jelena Vojicic, Paula Peyrani, et al.
Mbio|April 25, 2023
The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus InfectionAlexandra Hardy, Siddharth Bakshi, Wilhelm Furnon, et al.
Nature Protocols|October 23, 2015
Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchangeLaura R Hmelo, Bradley R Borlee, Henrik Almblad, et al.
Pageof 46